Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:
“Investigators at UCLA previously reported the outcomes following HDR brachyablation for lung tumors treated from 2015 to 2019 (n = 25). In a contemporary update led by Michelle Eala, we now report our experience with this technique in patients treated from 2019 to 2022 (n=33) at ASTRO25.
Local control = 98%!! The combined experience will be published soon.”
Read Further: Day 1 Highlights from ASTRO 2025 by Drew Moghanaki.